Topas is open to various types of collaborations. The Company plans to partner its proprietary programs at the clinical or pre-clinical stage on an option or a classical licensing basis with biotech or pharmaceutical companies. Topas is also interested in pre-clinical co-development agreements with biotech or academia that have complementary know-how and capabilities. Topas is open to collaborating with pharmaceutical and biotech companies on select indications proposed by the respective partner.

Business Development Contact

Companies interested in discussing potential collaboration opportunities with Topas are invited to contact:

Klaus Martin, PhD
CEO / Managing Director